324 related articles for article (PubMed ID: 35495618)
1. 'Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics'.
Mehmood S; Faheem M; Ismail H; Farhat SM; Ali M; Younis S; Asghar MN
Front Mol Biosci; 2022; 9():783494. PubMed ID: 35495618
[TBL] [Abstract][Full Text] [Related]
2. Multiomics insights on the onset, progression, and metastatic evolution of breast cancer.
Alvarez-Frutos L; Barriuso D; Duran M; Infante M; Kroemer G; Palacios-Ramirez R; Senovilla L
Front Oncol; 2023; 13():1292046. PubMed ID: 38169859
[TBL] [Abstract][Full Text] [Related]
3. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
4. Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine.
Kim K; Ku CR; Lee EJ
Endocrinol Metab (Seoul); 2023 Oct; 38(5):463-471. PubMed ID: 37828709
[TBL] [Abstract][Full Text] [Related]
5. Resistance and Overcoming Resistance in Breast Cancer.
Luque-Bolivar A; Pérez-Mora E; Villegas VE; Rondón-Lagos M
Breast Cancer (Dove Med Press); 2020; 12():211-229. PubMed ID: 33204149
[TBL] [Abstract][Full Text] [Related]
6. Imaging and the completion of the omics paradigm in breast cancer.
Leithner D; Horvat JV; Ochoa-Albiztegui RE; Thakur S; Wengert G; Morris EA; Helbich TH; Pinker K
Radiologe; 2018 Nov; 58(Suppl 1):7-13. PubMed ID: 29947931
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Interactome Multiomics Characterization for Cancer Research and Personalized Medicine: An Expert Review.
Sindhu KJ; Venkatesan N; Karunagaran D
OMICS; 2021 Sep; 25(9):545-566. PubMed ID: 34448651
[TBL] [Abstract][Full Text] [Related]
8. The next generation personalized models to screen hidden layers of breast cancer tumorigenicity.
Afzali F; Akbari P; Naderi-Manesh H; Gardaneh M
Breast Cancer Res Treat; 2019 Jun; 175(2):277-286. PubMed ID: 30810866
[TBL] [Abstract][Full Text] [Related]
9. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
11. Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments.
Gómez-Cebrián N; Domingo-Ortí I; Poveda JL; Vicent MJ; Puchades-Carrasco L; Pineda-Lucena A
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572770
[TBL] [Abstract][Full Text] [Related]
12. Potential biomarker panels in overall breast cancer management: advancements by multilevel diagnostics.
Girotra S; Yeghiazaryan K; Golubnitschaja O
Per Med; 2016 Sep; 13(5):469-484. PubMed ID: 29767597
[TBL] [Abstract][Full Text] [Related]
13. Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review.
Freitas AJA; Causin RL; Varuzza MB; Hidalgo Filho CMT; Silva VDD; Souza CP; Marques MMC
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771640
[TBL] [Abstract][Full Text] [Related]
14. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia.
Long L; Assaraf YG; Lei ZN; Peng H; Yang L; Chen ZS; Ren S
Drug Resist Updat; 2020 Sep; 52():100703. PubMed ID: 32599434
[TBL] [Abstract][Full Text] [Related]
15. MRI as a biomarker for breast cancer diagnosis and prognosis.
Galati F; Rizzo V; Trimboli RM; Kripa E; Maroncelli R; Pediconi F
BJR Open; 2022; 4(1):20220002. PubMed ID: 36105423
[TBL] [Abstract][Full Text] [Related]
16. Panoptic View of Prognostic Models for Personalized Breast Cancer Management.
Saini G; Mittal K; Rida P; Janssen EAM; Gogineni K; Aneja R
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31500225
[TBL] [Abstract][Full Text] [Related]
17. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
18. Responding to the challenges of breast cancer in egypt and other arab countries.
El Saghir NS
J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
